Patents by Inventor Barbara T. Merchant

Barbara T. Merchant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?2 andrenergic polymorphism detection
    Patent number: 7211381
    Abstract: Nucleic acid sequences are provided that are useful as amplification primers and hybridization probes for amplifying and detecting target sequence from the ?2 adrenergic receptor gene. The primers and probes can be employed in amplification based methods for detecting the presence of the target sequence in a test sample.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: May 1, 2007
    Assignee: Abbott Laboratories
    Inventors: Hong Yu, Barbara T. Merchant
  • Beta 2 adrenergic polymorphism detection
    Patent number: 6593092
    Abstract: Nucleic acid sequences are provided that are useful as amplification primers, hybridization probes, and as a portion of molecular beacon probes for amplifying and detecting polymorphisms of the &bgr;2 adrenergic receptor gene, compositions and kits incorporating the same, and methods employing the same.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: July 15, 2003
    Assignee: Abbott Laboratories
    Inventors: Hong Yu, Barbara T. Merchant
  • Beta 2 adrenergic polymorphism detection
    Publication number: 20020137069
    Abstract: Nucleic acid sequences are provided that are useful as amplification primers, hybridization probes, and as a portion of molecular beacon probes for amplifying and detecting polymorphisms of the &bgr;2 adrenergic receptor gene, compositions and kits incorporating the same, and methods employing the same.
    Type: Application
    Filed: October 9, 2001
    Publication date: September 26, 2002
    Inventors: Hong Yu, Barbara T. Merchant
  • Fluorescent enzyme substrates
    Patent number: 5998593
    Abstract: Fluorescent enzyme substrates are provided. The substrates are derivatives of coumarin having an enzyme cleavable group at position 7 and a hydrophilic amide group at position 4. The compounds are highly water soluble, stable at ambient and reduced temperatures and fluoresce upon cleavage by an enzyme.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: December 7, 1999
    Assignee: Abbott Laboratories
    Inventors: Jeffrey B. Huff, Barbara T. Merchant, Carolyn R. Mullen, Seshagiri R. Tata Venkata